In this scenario, the most studied receptor that plays a crucial role in the pathogenesis of CLL is the B Cell Receptor (BCR), which sustains the malignant phenotype of CLL cells via antigen-dependent engagement or autonomous autoactivation [17,18]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.